FILTER

FILTERED ARTICLE RESULTS

The 2020s: India’s decade?

November 19, 2019
As 2020 approaches, GBR takes a look at how far India has come to achieving its Pharma Vision 2020

U.S. Pharmaceuticals: The East Coast

July 25, 2019
From New England to the Mid-Atlantic, a rising tide lifts all boats across the biopharma value chain.

Serialization Regulations Put Packaging Into the Limelight

April 24, 2019
Changing serialization requirements represent an opportunity for packaging companies that are looking to add value for their clients.

Breaking Down Drug Pricing

April 01, 2019
The U.S. biopharmaceuticals industry continues to grapple with the perennial issue of drug pricing.

Standing Out in the Biotech Crowd: The VC Investment Climate

February 06, 2019
With biotechs now accounting for 70% of clinical trials in the United States, the VC private investment climate is heating up.

The Indispensable Partner: Contract Services

October 31, 2018
Large Pharma companies often turn to CMOs and CDMOs for specialized expertise, while Biotech startups rely upon their labs and hardware, resulting in a rapidly expanding and increasingly global business.

From Volume to Value: A Shift in Innovation Focus in the U.S.

August 30, 2018
Precision medicine and the understanding that every patient is different are driving drug discovery.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

Mexico Chemicals 2024

In August 2023, Mexican exports to the US surpassed China for the first time. As companies prioritize securing supply their chains after years of logistics challenges, Mexico has begun to see major benefits. With a spate of new infrastructure projects such as the Interoceanic Corridor of the Isthmus of Tehuantepec coming online in 2023, the country is actively opening itself to investment. The chemical industry, in particular, is positioned for nearshoring-driven growth.

PARTNER EVENTS